Literature DB >> 6472818

Pupillary and iridovitreal block in pseudophakic eyes.

C E Shrader, C D Belcher, J V Thomas, R J Simmons, E B Murphy.   

Abstract

Twenty-six cases of pupillary and iridovitreal block in pseudophakic eyes are reported. Although ten patients presented with acute angle closure glaucoma, the majority were asymptomatic and had normal intraocular pressures. While cure was finally achieved in all cases, recurrence of block occurred in six eyes as late as two months after initial successful treatment. A variety of therapeutic modalities including argon laser iridectomy, argon laser gonioplasty (iridoplasty), surgical iridectomy, surgical vitrectomy, Q-switched Nd:YAG laser iridectomy and Nd:YAG laser photodisruption of the anterior vitreous face were needed. Despite successful relief of pupillary and iridovitreal block in these eyes with no evidence of glaucoma prior to cataract and lens implant surgery, four eyes developed eight or more clock hours of peripheral anterior synechiae, and nine eyes continue to require chronic medical therapy for glaucoma.

Entities:  

Mesh:

Year:  1984        PMID: 6472818     DOI: 10.1016/s0161-6420(84)34230-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Surgical results and complications of goniosynechialysis.

Authors:  H Tanihara; K Nishiwaki; M Nagata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  Nasolacrimal obstruction and facial bone histopathology in craniodiaphyseal dysplasia.

Authors:  D A McHugh; G E Rose; A Garner
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

3.  Treatment of aphakic malignant glaucoma using Nd:YAG laser posterior capsulotomy.

Authors:  B C Little
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

4.  Pupillary block following posterior chamber intraocular lens implantation in adults.

Authors:  D D Gaton; K Mimouni; M Lusky; R Ehrlich; D Weinberger
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.